These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine. Grözinger M; Dragicevic A; Hiemke C; Shams M; Müller MJ; Härtter S Pharmacopsychiatry; 2003 Jan; 36(1):3-6. PubMed ID: 12649767 [TBL] [Abstract][Full Text] [Related]
9. Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Dahl ML; Bertilsson L Pharmacogenetics; 1993 Apr; 3(2):61-70. PubMed ID: 8100166 [No Abstract] [Full Text] [Related]
10. Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method. Jerling M; Merlé Y; Mentré F; Mallet A Br J Clin Pharmacol; 1994 Nov; 38(5):453-62. PubMed ID: 7893588 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Agúndez JA; Ledesma MC; Ladero JM; Benítez J Clin Pharmacol Ther; 1995 Mar; 57(3):265-9. PubMed ID: 7697944 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report. Gahr M; Gastl R; Kölle MA; Schönfeldt-Lecuona C; Freudenmann RW J Med Case Rep; 2012 Feb; 6():49. PubMed ID: 22309430 [TBL] [Abstract][Full Text] [Related]